Wal-Mart’s UK Arm Discovers Horse DNA and 4 Dow Movers to Follow

Johnson & Johnson (NYSE:JNJ): Current price $75.92

The company has advised physicians outside the United States to cease the use of its Adept hip implant following a higher-than-expected failure rate, says Bloomberg. A United Kingdom database discovered that 12 percent of patients subsequently required a repeat surgery to fix the implant which hasn’t been sold since 2011. Around 7,500 of the hips were distributed in 21 countries other than the United States.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!